References
- Kelley CF , KitchenCM , HuntPWet al. Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clin. Infect. Dis.48(6), 787–794 (2009).
- Pickard JM , ZengMY , CarusoR , NúñezG. Gut microbiota: role in pathogen colonization, immune responses, and inflammatory disease. Immunol. Rev.279(1), 70–89 (2017).
- Vujkovic-Cvijin I , SomsoukM. HIV and the gut microbiota: composition, consequences, and avenues for amelioration. Curr. HIV/AIDS Rep.16(3), 204–213 (2019).
- Ouyang J , LinJ , IsnardSet al. The bacterium Akkermansia muciniphila: a sentinel for gut permeability and its relevance to HIV-related inflammation. Front. Immunol.11, 645 (2020).
- Rocafort M , Noguera-JulianM , RiveraJet al. Evolution of the gut microbiome following acute HIV-1 infection. Microbiome7(1), 73 (2019).
- Cohen MS , ChenYQ , MccauleyMet al. Prevention of HIV-1 infection with early antiretroviral therapy. N. Engl. J. Med.365(6), 493–505 (2011).
- Serrano-Villar S , RojoD , Martínez-MartínezMet al. Gut bacteria metabolism impacts immune recovery in HIV-infected individuals. EBioMedicine8, 203–216 (2016).
- Lu W , FengY , JingFet al. Association between gut microbiota and CD4 recovery in HIV-1 infected patients. Front. Microbiol.9, 1451 (2018).
- Xie Y , SunJ , WeiLet al. Altered gut microbiota correlate with different immune responses to HAART in HIV-infected individuals. BMC Microbiol.21(1), 11 (2021).
- Nganou-Makamdop K , TallaA , SharmaAAet al. Translocated microbiome composition determines immunological outcome in treated HIV infection. Cell184(15), 3899–3914.e3816 (2021).
- Heung LJ , LubertoC , DelPoeta M. Role of sphingolipids in microbial pathogenesis. Infect. Immun.74(1), 28–39 (2006).
- Schenk B , FernandezF , WaechterCJ. The ins(ide) and out(side) of dolichyl phosphate biosynthesis and recycling in the endoplasmic reticulum. Glycobiology11(5), 61r–70r (2001).
- Archin NM , MargolisDM. Emerging strategies to deplete the HIV reservoir. Curr. Opin. Infect. Dis.27(1), 29–35 (2014).
- Wegiel B , OtterbeinLE. Go green: the anti-inflammatory effects of biliverdin reductase. Front. Pharmacol.3, 47 (2012).
- Davar D , DzutsevAK , MccullochJAet al. Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients. Science371(6529), 595–602 (2021).
- Geng ST , ZhangJB , WangYXet al. Pre-digested protein enteral nutritional supplementation enhances recovery of CD4(+) T cells and repair of intestinal barrier in HIV-infected immunological non-responders. Front. Immunol.12, 757935 (2021).
- Olivas-Martínez I , Rosado-SánchezI , Cordero-VarelaJAet al. Partial restoration of gut-mucosal dysbiosis in late-treated HIV-infected subjects with CD4 T-cell recovery. Clin. Transl. Med.12(4), e788 (2022).